National Assembly set to screen 38 bills

Published: 2011-11-04 07:00:00

Updated: 2011-11-04 07:00:00

The National Assembly’s Health and Welfare Committee is expected to examine a total of 38 bills on November 9, including a bill to seek an approval of autologous cell therapy (ACT) with a Phase I study data only, when it is intended for treatment of rare, intractable or life-threatening diseases....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK